ArticleOncogene2025

SPOP/NOLC1/B4GALT1 signaling axis enhances paclitaxel resistance in endometrial cancer by inducing O-dysglycosylation.

Fengguang Zhai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.